Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Age-related immune response differences after influenza or herpes zoster vaccination
NL-OMON50860Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2021
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of influenza vaccine, Zoster vaccine recombinant and Placebo-COD Research Private Ltd in influenza and herpes zoster (HZ) (5 arms), sponsored by Radboud University Medical Center. Primary endpoint: Functional assessment of vaccine response. Started Sep 2021; status: active, not recruiting.
02
Drugs
influenza vaccineZoster vaccine recombinantPlacebo-COD Research Private Ltd
03
Conditions
influenzaherpes zoster (HZ)
Beyond the preview
Go deeper on NL-OMON50860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50860.